{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Allen SW"],"funding":["Centers for Disease Control and Prevention","NIAID NIH HHS","National Institutes of Health","NIH HHS","CDC HHS"],"pagination":["e1031-e1038"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11565896"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["230(5)"],"pubmed_abstract":["There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, but it was unclear whether there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately before the epidemic. We found that 69 of 2938 sampled individuals (2.4%) were seropositive to CHIKV. Seropositivity to dengue virus (adjusted odds ratio, 3.13 [95% confidence interval, 1.86-5.27]), male sex (0.59 [.36-.99]), and community presence of Aedes aegypti mosquitoes (1.80 [1.05-3.0]7) were significantly associated with CHIKV seropositivity. Using a spatial prediction model, we estimated that across the country, 4.99 (95% confidence interval, 4.89-5.08) million people had been previously "],"journal":["The Journal of infectious diseases"],"pubmed_title":["Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh."],"pmcid":["PMC11565896"],"funding_grant_id":["U01 AI151801","U01AI151801","R24 AI120942"],"pubmed_authors":["Allen SW","Paul KK","Rahman MZ","Alam MS","Smull T","Paul R","Rahman M","Gurley ES","Salje H","Ribeiro Dos Santos G","Weaver SC","Al-Amin HM","Vanhomwegen J","Lee KH"],"additional_accession":[]},"is_claimable":false,"name":"Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh.","description":"There is an increasing global burden from chikungunya virus (CHIKV). Bangladesh reported a major epidemic in 2017, but it was unclear whether there had been prior widespread transmission. We conducted a nationally representative seroprevalence survey in 70 randomly selected communities immediately before the epidemic. We found that 69 of 2938 sampled individuals (2.4%) were seropositive to CHIKV. Seropositivity to dengue virus (adjusted odds ratio, 3.13 [95% confidence interval, 1.86-5.27]), male sex (0.59 [.36-.99]), and community presence of Aedes aegypti mosquitoes (1.80 [1.05-3.0]7) were significantly associated with CHIKV seropositivity. Using a spatial prediction model, we estimated that across the country, 4.99 (95% confidence interval, 4.89-5.08) million people had been previously ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-07-16T22:37:59.048Z","creation":"2025-04-05T18:41:27.892Z"},"accession":"S-EPMC11565896","cross_references":{"pubmed":["38942731"],"doi":["10.1093/infdis/jiae335"]}}